T45.602

Clinical Causes: Intentional self-harm through deliberate ingestion of fibrinolysis-affecting drugs Accidental overdose, especially in individuals with access to such medications Misuse of prescription medicines that influence the fibrinolytic system Lack of awareness about the potential toxicity of these drugs

Key Symptoms: Unusual bleeding or bruising Blood in urine or stools Gastrointestinal bleeding such as vomiting blood or passing blood-tinged stools Dizziness or lightheadedness, especially when standing Signs of shock in severe cases, such as rapid heartbeat and low blood pressure Pain or swelling in areas prone to bleeding

Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Healthcare providers may inquire about recent medication use and any history of suicidal thoughts or behaviors. Blood tests are crucial to determine the extent of bleeding, measure clotting times, and identify the specific substances involved. Additional assessments such as imaging studies could be used to evaluate internal bleeding or injuries. Proper diagnosis helps in tailoring appropriate treatment strategies and evaluating the severity of poisoning.

Treatment Protocols: Treatment approaches focus on stabilizing the patient and preventing further bleeding. Immediate steps may include discontinuing the offending medication and providing supportive care such as intravenous fluids and blood transfusions if necessary. Pharmacological interventions, like administering antidotes or agents that promote clotting, could be considered. In some cases, procedures to remove toxins or treat internal bleeding may be required. Mental health support and counseling are essential for patients engaging in self-harm behaviors, along with strategies to prevent recurrence. Multidisciplinary management aims to address both the physical and psychological aspects of this condition.